493 related articles for article (PubMed ID: 18413212)
1. TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients.
Gustavsson C; Agardh E; Bengtsson B; Agardh CD
J Diabetes Complications; 2008; 22(5):309-16. PubMed ID: 18413212
[TBL] [Abstract][Full Text] [Related]
2. The role of vascular endothelial growth factor, tumor necrosis factor alpha and interleukin-6 in pathogenesis of diabetic retinopathy.
Myśliwiec M; Balcerska A; Zorena K; Myśliwska J; Lipowski P; Raczyńska K
Diabetes Res Clin Pract; 2008 Jan; 79(1):141-6. PubMed ID: 17716775
[TBL] [Abstract][Full Text] [Related]
3. [Contribution of selected cellular adhesion molecules and proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy].
Adamiec J; Oficjalska-Młyńczak J
Przegl Lek; 2007; 64(6):389-92. PubMed ID: 18159844
[TBL] [Abstract][Full Text] [Related]
4. Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy.
Demircan N; Safran BG; Soylu M; Ozcan AA; Sizmaz S
Eye (Lond); 2006 Dec; 20(12):1366-9. PubMed ID: 16284605
[TBL] [Abstract][Full Text] [Related]
5. Relationship between polymorphisms 804C/A and 252A/G of lymphotoxin-alpha gene and -308G/A of tumor necrosis factor alpha gene and diabetic retinopathy in Japanese patients with type 2 diabetes mellitus.
Yoshioka K; Yoshida T; Takakura Y; Umekawa T; Kogure A; Toda H; Yoshikawa T
Metabolism; 2006 Oct; 55(10):1406-10. PubMed ID: 16979413
[TBL] [Abstract][Full Text] [Related]
6. Severity of diabetic retinopathy is linked to lipoprotein (a) in type 1 diabetic patients.
Guerci B; Meyer L; Sommer S; George JL; Ziegler O; Drouin P; Angioï-Duprez K
Diabetes Metab; 1999 Nov; 25(5):412-8. PubMed ID: 10592864
[TBL] [Abstract][Full Text] [Related]
7. Cytokine profile of peripheral blood in type 2 diabetes mellitus patients with diabetic retinopathy.
Lee JH; Lee W; Kwon OH; Kim JH; Kwon OW; Kim KH; Lim JB
Ann Clin Lab Sci; 2008; 38(4):361-7. PubMed ID: 18988929
[TBL] [Abstract][Full Text] [Related]
8. Roles of endothelin-1 and selected proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy: Analysis of vitreous samples.
Adamiec-Mroczek J; Oficjalska-Młyńczak J; Misiuk-Hojło M
Cytokine; 2010 Mar; 49(3):269-74. PubMed ID: 20015663
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil surface expression of CD11b and CD62L in diabetic microangiopathy.
Mastej K; Adamiec R
Acta Diabetol; 2008 Sep; 45(3):183-90. PubMed ID: 18496641
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine-immune disorder in type 2 diabetic patients with retinopathy.
Obulkasim M; Turdi A; Amat N; Haxim M; Eziz R; Haji H; Li L; Chen X; Upur H; Ren J
Clin Exp Pharmacol Physiol; 2011 Apr; 38(4):229-32. PubMed ID: 21281334
[TBL] [Abstract][Full Text] [Related]
11. Oral glucose tolerance test effects on endothelial inflammation markers in healthy subjects and diabetic patients.
Derosa G; D'Angelo A; Salvadeo SA; Ferrari I; Fogari E; Gravina A; Mereu R; Palumbo I; Maffioli P; Randazzo S; Cicero AF
Horm Metab Res; 2010 Jan; 42(1):8-13. PubMed ID: 19735057
[TBL] [Abstract][Full Text] [Related]
12. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus.
Doganay S; Evereklioglu C; Er H; Türköz Y; Sevinç A; Mehmet N; Savli H
Eye (Lond); 2002 Mar; 16(2):163-70. PubMed ID: 11988817
[TBL] [Abstract][Full Text] [Related]
13. Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial.
Schaumberg DA; Glynn RJ; Jenkins AJ; Lyons TJ; Rifai N; Manson JE; Ridker PM; Nathan DM
Circulation; 2005 May; 111(19):2446-53. PubMed ID: 15867184
[TBL] [Abstract][Full Text] [Related]
14. [Interleukin-12, vascular endothelial growth factor and tumor necrosis factor-alpha in the process of neoangiogenesis of diabetic retinopathy in children].
Zorena K; Myśliwska J; Myśliwiec M; Balcerska A; Lipowski P; Raczyńska K
Klin Oczna; 2007; 109(4-6):155-9. PubMed ID: 17725275
[TBL] [Abstract][Full Text] [Related]
15. Profile of intraocular tumour necrosis factor-α and interleukin-6 in diabetic subjects with different degrees of diabetic retinopathy.
Gustavsson C; Agardh CD; Agardh E
Acta Ophthalmol; 2013 Aug; 91(5):445-52. PubMed ID: 22520269
[TBL] [Abstract][Full Text] [Related]
16. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
Navarro JF; Mora C; Gómez M; Muros M; López-Aguilar C; García J
Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
[TBL] [Abstract][Full Text] [Related]
17. Not all inflammatory markers are linked to kidney function: results from a population-based study.
Pruijm M; Ponte B; Vollenweider P; Mooser V; Paccaud F; Waeber G; Marques-Vidal P; Burnier M; Bochud M
Am J Nephrol; 2012; 35(3):288-94. PubMed ID: 22398717
[TBL] [Abstract][Full Text] [Related]
18. Elevation of tumor necrosis factor-alpha, interleukin-1beta and interleukin-6 levels in aortic intima of Chinese Guizhou minipigs with streptozotocin-induced diabetes.
Lu L; Zhang Q; Pu LJ; Xu XW; Zhang RY; Zhang JS; Hu J; Yang ZK; Lü AK; Ding FH; Shen J; Chen QJ; Lou S; Fang DH; Shen WF
Chin Med J (Engl); 2007 Mar; 120(6):479-84. PubMed ID: 17439741
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein and risk factors for peripheral vascular disease in subjects with Type 2 diabetes mellitus.
Yu HI; Sheu WH; Song YM; Liu HC; Lee WJ; Chen YT
Diabet Med; 2004 Apr; 21(4):336-41. PubMed ID: 15049935
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy.
Hernández C; Segura RM; Fonollosa A; Carrasco E; Francisco G; Simó R
Diabet Med; 2005 Jun; 22(6):719-22. PubMed ID: 15910622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
